BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30641602)

  • 1. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
    Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
    Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
    Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
    Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
    Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
    Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
    Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
    J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli.
    Jeannot E; Wendum D; Paye F; Mourra N; de Toma C; Fléjou JF; Zucman-Rossi J
    J Hepatol; 2006 Dec; 45(6):883-6. PubMed ID: 17049664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Adenomas: Morphology and Genomics.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α.
    Ding CH; Deng LF; Chen F; Ding K; Chen WS; Xie WF; Zhang X
    Biochem Biophys Res Commun; 2018 Jan; 495(1):86-91. PubMed ID: 29101032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation.
    Bacq Y; Jacquemin E; Balabaud C; Jeannot E; Scotto B; Branchereau S; Laurent C; Bourlier P; Pariente D; de Muret A; Fabre M; Bioulac-Sage P; Zucman-Rossi J
    Gastroenterology; 2003 Nov; 125(5):1470-5. PubMed ID: 14598263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review].
    Hirata E; Shimizu S; Umeda S; Kobayashi T; Nakano M; Higuchi H; Serizawa H; Iwasaki N; Morinaga S; Tsunematsu S
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1696-704. PubMed ID: 26346360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
    Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
    Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.
    Stueck AE; Qu Z; Huang MA; Campreciós G; Ferrell LD; Thung SN
    Semin Liver Dis; 2015 Nov; 35(4):444-9. PubMed ID: 26676820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Adenomas: Classification, Controversies, and Consensus.
    Torbenson M
    Surg Pathol Clin; 2018 Jun; 11(2):351-366. PubMed ID: 29751879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
    Evason KJ; Grenert JP; Ferrell LD; Kakar S
    Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.